TwinBeech Capital’s Soleno Therapeutics SLNO Stock Holding History

TwinBeech Capital’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,200	Closed	-$877K	–	655
2026 Q1	$877K	Buy	+26,200	New	+$1.03M	0.09%	280
2024 Q4	–	Sell	-53,243	Closed	-$2.69M	–	905
2024 Q3	$2.69M	Buy	+53,243	New	+$2.55M	0.05%	368

TwinBeech Capital's SLNO Position: Q2 2026 in Review

TwinBeech Capital sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 26,200 shares — an estimated $877K sold.

TwinBeech Capital first reported a position in SLNO in Q3 2024 and held it in 2 quarters. The position peaked at $2.69M in Q3 2024. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

TwinBeech Capital reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
TwinBeech Capital sold 26,200 Soleno Therapeutics shares in Q2 2026, an estimated $877K.
TwinBeech Capital first reported a position in Soleno Therapeutics in Q3 2024 and held it in 2 quarters.
TwinBeech Capital's Soleno Therapeutics position peaked at $2.69M in Q3 2024.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.